C-reactive protein, heart disease risk, and the popular media.

R. Tracy,L. Kuller

DOI: https://doi.org/10.1001/ARCHINTE.165.18.2058

2005-10-10

Archives of Internal Medicine

Abstract:

What problem does this paper attempt to address?

Integrated Proteomics and Metabolomics to Study IgA Nephropathy on Early Stage and Identification of Biomarkers

Di Zhang,Yaohan Li,Mingzhu Liang,Yan Liang,Jianmin Tian,Qiang He,Juan Jin,Wei Zhu

DOI: https://doi.org/10.21203/rs.3.rs-2177109/v1

2022-01-01

Abstract:Background IgA nephropathy (IgAN) is the most common primary chronic glomerulopathy globally. For IgAN diagnosis, kidney biopsy is still the standard method, which is invasive. And there are no effective plasma biomarkers for the disease at the early stage. The research aimed to find potential biomarkers for diagnosing IgAN. Methods Plasma samples of 33 early-stage IgAN patients who were not taking hormonal drugs and 20 healthy controls were collected for proteomic and metabolomic analysis. The least absolute shrinkage and selection operator (LASSO) was used to construct a binary logistic regression model by combining proteomic and metabolomic data. The area under the curve (AUC) of the receiver operating characteristic (ROC) curve, sensitivity, and specificity test were performed to assess the model's performance. Results Proteomic analysis of IgAN plasma revealed that the complement and the immune system were activated. And the metabolomic result showed that energy and amino acid metabolism were disordered in IgAN patients. Through machine learning, PRKAR2A, IL6ST, SOS1, and palmitoleic acid have been identified as potential biomarkers. Based on the AUC value for the training and test sets, the classification performance was 0.994 and 0.977, respectively. The AUC of the external validation of the four biomarkers was 0.91. Conclusion In this study, we applied proteomics and metabolomics techniques to analyze the plasma of IgAN patients and find biomarkers. PRKAR2A, IL6ST, SOS1, and palmitoleic acid were combined to serve as potential biomarkers for early diagnosis of IgAN.
Urinary Proteome Analysis by Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight Mass Spectrometry with Magnetic Beads for Identifying the Pathologic Presentation of Clinical Early Iga Nephropathy

Qiang He,Lina Shao,Jiekai Yu,Shunxian Ji,Huiping Wang,Youying Mao,Jianghua Chen

DOI: https://doi.org/10.1166/jbn.2012.1364

2012-01-01

Journal of Biomedical Nanotechnology

Abstract:IgA nephropathy is the most common type of chronic glomerulonephritis which leads eventually to end-stage renal disease (ESRD). The duration of clinical early stage IgA nephropathy to ESRD varies a lot. The pathologic presentation may have detrimental effect on outcome. But the renal biopsy is a high-risk invasive operation not able to be accepted by all patients. In this study, we tried to find biomarkers in urine as a non-invasive approach to diagnose different pathologic presentations of clinical early stage IgA nephropathy. A total of 56 patients with IgA nephropathy were included in this study, with 23 patients having severe pathologic presentation and the other 33 having mild ones. The control group consisted of 14 normal subjects. The urinary proteomic spectra from those three groups were generated by Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) with weak cationic exchange magnetic beads. The total experiment data was handled by the Zhejiang University ProteinChip Data Analysis System. We found that the urine protein/peptide spectra patterns could be established to distinguish severe IgA nephropathy from the mild IgA nephropathy group and the normal group. Several potential biomarkers were found and the diagnostic system could distinguish between severe IgA nephropathy from the mild IgA nephropathy with a sensitivity of 90.48% and specificity of 96.77%. We conclude that, using MALDI-TOF-MS with magnetic beads to detect urine proteomic patterns shows great potential in identifying early IgA nephropathy with different pathologic prognosis.
Itraq-Based Comparative Proteomics Analysis Reveals Specific Urinary Biomarkers for Various Kidney Diseases.

Juan Jin,Jianguang Gong,Li Zhao,Yiwen Li,Yunguang Wang,Qiang He

DOI: https://doi.org/10.21203/rs.2.13809/v1

2020-01-01

Biomarkers in Medicine

Abstract:Background: Proteome studies for multiple renal diseases is bare. Methodology & results: Using isobaric tags for relative and absolute quantitation labeling, many differentially expressed proteins (DEPs) were identified in acute kidney injury (AKI), AKI + chronic kidney disease (CKD), diabetic CKD and nondiabetic CKD with or without IgA nephropathy (IgAN). Comparative analysis indicated that 34, 35, 17, 91 and 14 unique DEPs were found in AKI, AKI + CKD, CKD, diabetic CKD and nondiabetic CKD. Compared with nondiabetic CKD with IgAN, 47 unique DEPs were found in that without IgAN. Serum amyloid A1 (SAA1) and hepatocyte growth factor activator were unregulated in AKI and nondiabetic CKD without IgAN, respectively. Regenerating islet-derived protein 3-α (Reg3A) upregulation is associated with AKI and AKI + CKD patients. Conclusion: This research contributes to urinary biomarker discovery from multiple renal diseases.
Proteome analysis reveals novel serum biomarkers for Henoch-Schönlein purpura in Chinese children

Li Liu,Hailing Liu,Kaili Zhu,Lingyu Zhang,Xiaomei Yin,Lin Han,Miaomiao Wang,Shanfeng Gao,Xuan Xiao,Juan Yang,Chen Huang,Yanping Huang

DOI: https://doi.org/10.1016/j.jprot.2023.104841

2023-03-30

Abstract:Purpose: Henoch-Schönlein purpura (HSP) is diagnosed based on characteristic skin changes. This study aimed to identify the serum biomarkers of HSP in children. Experimental design: We performed proteomic analysis of serum samples from 38 paired pre- and posttherapy HSP patients and 22 healthy controls using a combination of magnetic bead-based weak cation exchange and MALDI-TOF MS. ClinProTools was used to screen the differential peaks. Then, LC-ESI-MS/MS was performed to identify the proteins. ELISA was used to verify the expression of whole protein in the serum of 92 HSP patients, 14 peptic ulcer disease (PUD) patients and 38 healthy controls, which were prospectively collected. Finally, logistic regression analysis was performed to analyze the diagnostic value of the above predictors and existing clinical indicators. Results: Seven potential HSP serum biomarker peaks (m/z:1228.95, m/z:1781.22, m/z:1468.43, m/z:1619.53, m/z:1868.41, m/z:1694.05, m/z:1743.25) with higher expression in the pretherapy group and one peak (m/z:1947.41) with lower expression in the pretherapy group were all identified as peptide regions of albumin (ALB), complement C4-A precursor (C4A), tubulin beta chain (TUBB), isoform 1 of fibrinogen alpha chain (FGA), and ezrin (EZR). The expression of identified proteins was validated by ELISA. Multivariate logistic regression analysis showed that serum C4A EZR and ALB were independent risk factors for HSP, serum C4A and lgA were independent risk factors for HSPN, and serum D-dimer was an independent risk factor for abdominal HSP. Conclusions and clinical relevance: These findings revealed the specific etiology of HSP from the perspective of serum proteomics. The identified proteins might serve as potential biomarkers for HSP and HSPN diagnoses. Significance: Henoch-Schönlein purpura (HSP) is the most common systemic vasculitis in children, and its diagnosis depends primarily on characteristic skin changes. Early diagnosis of non-rash patients is difficult, especially for abdominal and renal types (Henoch-Schönlein purpura nephritis, HSPN). HSPN has poor outcomes, is diagnosed based on urinary protein and/or haematuria, and cannot be detected early in HSP. Patients with an earlier diagnosis of HSPN appear to have better renal outcomes. Our plasma proteomic analysis of HSP in children revealed that HSP patients could be distinguished from healthy controls and peptic ulcer disease patients using complement C4-A precursor (C4A), ezrin, and albumin. C4A and IgA could distinguish HSPN from HSP in the early stages, and D-dimer was a sensitive index used to distinguish abdominal HSP; identifying these biomarkers could promote the early diagnosis of HSP, especially pediatric HSPN and abdominal HSP, thereby improving precision therapy.
Identification of the Pathologic Presentation of Clinical Early IgA Nephropathy by MALDI-TOF-MS with Magnetic Beads

邵丽娜,何强,余捷凯,王慧萍,陈江华

2013-01-01

Abstract:Objective To search noninvasive methods to identify the pathologic presentation of early IgA nephropathy through urinary proteomic analysis. Methods Total 55 patients with IgA nephropathy were included in this study, with 23 patients having severe pathologic presentation, and the other 32 having mild ones. The control group included 14 normal subjects. The urinary proteomic spectra from those three groups were generated by Matrix- assisted laser desorption/ionization time- of- flight mass spectrometry (MALDI- TOF MS) with weak cationic exchange magnetic beads. Results Three Urine protein/peptide spectra patterns were established. In pattern one, the potential protein biomarkers could identify the severe group and the mild group, the sensitivity was 90.48%and the specificity was 96.77%. In pattern two, the potential protein biomarkers could identify the mild group and the normal group, the sensitivity was 93.55% and the specificity was 85.71%. In pattern three, The potential protein biomarker could identify the severe group and the normal group, the sensitivity was 100%and the specificity was 92.86%. Conclusion Using MALDI- TOF- MS with magnetic beads to detect urine proteomic patterns shows great potential in identifying early IgA nephropathy with different pathological manifestations.
Mouse peripherin isoforms

F. Landon,A. Wolff,B. Néchaud

DOI: https://doi.org/10.1016/S0248-4900(00)01099-6

2000-09-01

Biology of the Cell

Abstract:
Updated Oxford classification and the international study of kidney disease in children classification: application in predicting outcome of Henoch-Schönlein purpura nephritis

Xiaohan Huang,Lili Ma,Pingping Ren,Hongya Wang,Liangliang Chen,Haidongqin Han,Jianghua Chen,Fei Han

DOI: https://doi.org/10.1186/s13000-019-0818-0

2019-01-01

Diagnostic Pathology

Abstract:Henoch-Schönlein purpura nephritis (HSPN) shares many similarities with IgA nephropathy. We aimed to analyze the predictive value of the International Study of Kidney Disease in Children (ISKDC) classification and the updated Oxford classification for IgA nephropathy in HSPN patients. Data of 275 HSPN patients (aged≥14 years) were retrieved, and all of them underwent a renal biopsy. We re-classified the biopsies according to the ISKDC classification and the updated Oxford classification to analyze their correlations with clinical features and renal outcomes. The renal endpoints were defined as ≥30% reduction in baseline estimated glomerular filtration rate (eGFR) in 2 years, doubling of serum creatinine (Scr) or end stage renal disease. During follow-up period of 56(30,86) months, 30(10.9%) patients reached renal endpoints. Segmental sclerosis was the only pathological feature independently associated with renal endpoints (HR 4.086, 95%CI 1.111–15.026, P = 0.034). Tubular atrophy/ interstitial fibrosis was associated with eGFR and Scr levels, and its correlation with renal endpoints was found by univariate analysis. Endocapillary hypercellularity was associated with 24 h urine protein and is of prognostic value in univariate analysis. Mesangial hypercellularity was not associated with clinical features or renal endpoints. Crescents were associated with 24 h urine protein, Scr and eGFR levels, but both ISKDC and updated Oxford classifications of crescents were not associated with renal endpoints by multivariate analysis. The updated Oxford classification can help in disease management and renal outcome prediction of HSPN.
Preliminary Analysis on Urinary Proteomics of Children with Minimal Change Nephrotic Syndrome

HUANG Yan-jun,HUANG Song-ming,ZHANG Ai-hua,FEI li,XU Song-zhou,CHEN Rong-hua

DOI: https://doi.org/10.3969/j.issn.1005-8982.2006.20.035

2006-01-01

Abstract:[Objective] The aim of the research is to establish the two-dimensional gel electrophoresis and PDQUEST software based image analysis for the urinary proteome of children with minimal change nephrotic syndrome.[Methods] The urinary protein of children nephrotic syndrome was isolated by cold acetone precipitation,treated to remove high abundance proteins by Aurum Serum Protein Kit.The rehydrated IPG strips containing protein samples were isoelectric focusing(IEF),after IEF,the equilibrated strips are transferred to the vertical SDS gel.The silver stained gels were scanned by UMAX PowerLook 1120 densitometer,following PDQuest 7.3 analysis,the differentially expressed protein spots were found and excised from gel and digested with trypsin under optimal conditions.Masses of tryptic-digested peptides were acquired with a Voyager DA-STR matrix assisted laser desorption ionization time of flight(MALDI-TOF)mass spectrometer.[Results] Using the proper method stated above,satisfactory 2DGE maps of urinary protein was obtained and the preliminary analysis results were reported.A total of 400 protein spots were visualized in the patients with minimal change nephrotic syndrome,about 100 protein spots in the normal urine.Nine spots of proteins in gel were identified as Alpha-1-antitrypsin precursor,Zn-alpha-2-glycoprotein,Alpha-1B-glycoprotein,Haptoglobin,and PITPNB protein.[Conclusion] Urinary proteomics applied to the study of urine protein of children minimal change nephrotic syndrome is feasible.
Urinary complement proteins in IgA nephropathy progression from a relative quantitative proteomic analysis

Xia Niu,Shuyu Zhang,Chen Shao,Zhengguang Guo,Jianqiang Wu,Jianling Tao,Ke Zheng,Wenling Ye,Guangyan Cai,Wei Sun,Mingxi Li

DOI: https://doi.org/10.7717/peerj.15125

IF: 3.061

2023-04-11

PeerJ

Abstract:Aim IgA nephropathy (IgAN) is one of the leading causes of end-stage renal disease (ESRD). Urine testing is a non-invasive way to track the biomarkers used for measuring renal injury. This study aimed to analyse urinary complement proteins during IgAN progression using quantitative proteomics. Methods In the discovery phase, we analysed 22 IgAN patients who were divided into three groups (IgAN 1-3) according to their estimated glomerular filtration rate (eGFR). Eight patients with primary membranous nephropathy (pMN) were used as controls. Isobaric tags for relative and absolute quantitation (iTRAQ) labelling, coupled with liquid chromatography-tandem mass spectrometry, was used to analyse global urinary protein expression. In the validation phase, western blotting and parallel reaction monitoring (PRM) were used to verify the iTRAQ results in an independent cohort ( N = 64). Results In the discovery phase, 747 proteins were identified in the urine of IgAN and pMN patients. There were different urine protein profiles in IgAN and pMN patients, and the bioinformatics analysis revealed that the complement and coagulation pathways were most activated. We identified a total of 27 urinary complement proteins related to IgAN. The relative abundance of C3, the membrane attack complex (MAC), the complement regulatory proteins of the alternative pathway (AP), and MBL (mannose-binding lectin) and MASP1 (MBL associated serine protease 2) in the lectin pathway (LP) increased during IgAN progression. This was especially true for MAC, which was found to be involved prominently in disease progression. Alpha-N-acetylglucosaminidase (NAGLU) and α-galactosidase A (GLA) were validated by western blot and the results were consistent with the iTRAQ results. Ten proteins were validated in a PRM analysis, and these results were also consistent with the iTRAQ results. Complement factor B (CFB) and complement component C8 alpha chain (C8A) both increased with the progression of IgAN. The combination of CFB and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) also showed potential as a urinary biomarker for monitoring IgAN development. Conclusion There were abundant complement components in the urine of IgAN patients, indicating that the activation of AP and LP is involved in IgAN progression. Urinary complement proteins may be used as biomarkers for evaluating IgAN progression in the future.

multidisciplinary sciences
Proteomic Profile-Based Screening of Potential Protein Biomarkers in the Urine of Patients with Nephrotic Syndrome

Yu Wang,Chunxia Zheng,Xia Wang,Ke Zuo,Zhihong Liu

DOI: https://doi.org/10.3892/mmr.2017.7329

IF: 3.423

2017-01-01

Molecular Medicine Reports

Abstract:Nephrotic syndrome is not a single disease; rather, it is a term for numerous diseases and pathological types. Renal biopsy is of use in determining the diagnosis and prognosis, and for guiding treatment; however, the use of this intervention is limited due to its invasive nature. Abnormal kidney‑derived proteins in the urine of patients provide useful information regarding numerous pathological processes that occur in the kidneys, and may be considered a potential non‑invasive biomarker for kidney disease. Proteomic analysis exhibits the advantage of being high‑throughput and has previously been used to identify biomarkers of disease. The present study aimed to identify abnormal kidney‑derived proteins in the urine of patients with nephrotic syndrome using a novel proteomic strategy. Urine samples from 5 patients with nephrotic syndrome were subjected to acetone precipitation and albumin/immunoglobulin G depletion prior to analysis by two‑dimensional liquid chromatography tandem mass spectrometry. The resulting data were compared to a publicly available proteomic database of normal human plasma/urine and normal human kidney in PeptideAtlas, and of normal human kidney in the Human Protein Atlas. Candidate biomarkers were validated using ELISA analysis in 60 patients with nephrotic syndrome: 30 with focal segmental glomerulosclerosis (FSGS) and 30 with minimal change disease (MCD), as well as in 30 healthy controls. The initial screening identified 809 proteins in the urine of patients with nephrotic syndrome. A total of 13/809 proteins were additionally present in the kidney proteome of PeptideAtlas and the Human Protein Atlas, although not in normal human urine and normal human plasma according to PeptideAtlas; these were referred to as 'kidney‑derived disease‑associated proteins'. One of the kidney‑derived disease‑associated proteins, ubiquitin‑60S ribosomal protein L40 (UBA52) was observed to be increased in the urine of patients compared with normal controls [Creatinine, 637 ng/mg (216‑1,851) vs. 1.89 ng/mg (1.37‑3.33), P<0.001; and 18.58 ng/mg (11.11‑46.25) vs. 1.89 ng/mg (1.37‑3.33), P<0.001)], and the urinary UBA52 levels were significantly increased in patients with FSGS compared with in patients with MCD (P<0.001). In conclusion, the present study identified potential novel urinary protein biomarkers for nephrotic syndrome, in addition to an extensive urinary proteomic profile of patients with nephrotic syndrome.
Urinary biomarkers of IgA nephropathy and other IgA-associated renal diseases

Bruce A Julian,Stefan Wittke,Marion Haubitz,Petra Zürbig,Eric Schiffer,Brendan M McGuire,Robert J Wyatt,Jan Novak

DOI: https://doi.org/10.1007/s00345-007-0192-5

Abstract:IgA nephropathy is the most common primary glomerulonephritis and is a frequent cause for chronic kidney disease in children and young adults. Glomerular deposition of IgA also characterizes other renal disorders, including Henoch-Schoenlein purpura nephritis and immune-complex glomerulonephritis afflicting patients with liver disease due to chronic infection with the hepatitis C virus. Several treatment options are often considered, with the goal to prevent end-stage renal failure. Unfortunately, the diagnosis currently requires an invasive procedure, a renal biopsy. Because of the inherent risks, repetitive renal biopsy is frequently foregone as a means to monitor the clinical course or response to treatment. Recent advances in the analysis of the urinary proteome suggest that the excreted polypeptides include disease-specific patterns. We review recent studies of the various techniques for the identification and validation of such urinary biomarkers of IgA-associated glomerulonephritides. Currently, capillary electrophoresis coupled with mass spectrometry (MS) offers the greatest promise. To date, it seems more likely that disease-specific urinary polypeptide biomarkers are comprised of a panel of several distinct and well-defined peptides rather than a single molecule. Even most patients in clinical remission with normal clinical testing (dipstick urinalysis and quantitative proteinuria) were correctly classified by the pattern of polypeptides identified by capillary electrophoresis coupled with MS. With confirmation and refinement, such urinary testing may provide a tool for the diagnosis and monitoring of patients with IgA-associated renal diseases that is more sensitive than current standard clinical testing and far less risky than renal biopsy.
Angiopoietin-like Protein 3: a Novel Potential Biomarker for Nephrotic Syndrome in Children

Fujie Wen,Junchao Liu,Rufeng Dai,Sha Hong,Baowei Ji,Jiaojiao Liu,Jun Zhang,Xinli Han,Qianying Lv,Jialu Liu,Qian Shen,Hong Xu

DOI: https://doi.org/10.3389/fped.2023.1113484

IF: 3.569

2023-01-01

Frontiers in Pediatrics

Abstract:BackgroundAngiopoietin-like 3 (ANGPTL3) is a secretory glycoprotein. It has been demonstrated that ANGPTL3 level was upregulated in minimal change nephrotic syndrome (MCNS) kidney tissues. Subsequently, our group found that ANGPTL3 level was closely correlated with nephropathy in vivo and in vitro. Hence, whether ANGPTL3 level could be correlated with the proteinuria level, and assessment of disease severity of nephrotic syndrome (NS) remained to be investigated. This study aimed to analyzed the correlation between the levels of ANGPTL3 in serum and urine of patients with nephrotic syndrome and proteinuria, and assessed the severity of the patients' disease. In future clinical translation, the level of ANGPTL3 in serum, urine will be used as a biomarker to better predict the development of nephrotic syndrome.MethodsA total of 200 NS patients and 80 healthy controls (age, 1–18 years) were admitted to our institution between 2021 and 2022. The etiology of NS included primary nephrotic syndrome (PNS, n = 144) and NS with other causes (n = 56). A total of 280 serum samples and 244 urinary samples were collected to determine ANGPTL3 level using enzyme-linked immunosorbent assay (ELISA).ResultsSerum ANGPTL3 and urinary ANGPTL3/Cre were remarkably elevated in NS patients compared with those in healthy controls. Furthermore, serum ANGPTL3 and urinary ANGPTL3/Cre were significantly correlated with proteinuria level. Additionally, multivariate linear regression analysis demonstrated that serum ALB was independently correlated with serum ANGPTL3 and PRO/CR was independently correlated with urinary ANGPTL3/Cre in NS patients.ConclusionSerum ANGPTL3 and urinary ANGPTL3/Cre showed a promising performance in the diagnosis of NS, and served as novel potential noninvasive biomarkers to assess disease severity of NS. Further exploration of the role of ANGPTL3 level may shed a new light on the treatment of NS.
Biomarkers identification by a combined clinical and metabonomics analysis in Henoch-Schonlein purpura nephritis children

Lin Sun,Biao Xie,Qiuju Zhang,Yupeng Wang,Xinyu Wang,Bing Gao,Meina Liu,Maoqing Wang

DOI: https://doi.org/10.18632/oncotarget.23207

2017-11-24

Oncotarget

Abstract:Background: In children with Henoch-Schonlein purpura (HSP), the severity of Henoch-Schonlein purpura nephritis (HSPN) is considered responsible for the prognosis of HSP. The pathological process from HSP to HSPN is not clear yet and current diagnostic tools have shortcomings in accurate diagnosis of HSPN. This study aims to assess clinical characteristics of HSP and HSPN, to identify metabolic perturbations involved in HSP progress, and to combine metabolic biomarkers and clinical features into a better prediction for HSPN. Methods: A total of 162 children were recruited, including 109 HSP patients and 53 healthy children (HC). The clinical characteristics were compared between HSPN and HSP without nephritis (HSPWN). The serum metabonomics analysis was performed to determine the metabolic differences in HSP and HC. Results: Among 109 HSP children, 57 progressed to HSPN. The increased D-dimer level was significantly associated with renal damage in HSP. The metabonomic profiles revealed alterations between various subgroups of HSP and HC, making it possible to investigate small-molecule metabolites related to the pathological process of HSP. In total, we identified 9 biomarkers for HSP vs. HC, 7 for HSPWN vs. HC, 9 for HSPN vs. HC, and 3 for HSPN vs. HSPWN. Conclusions: (S)-3-hydroxyisobutyric acid, p-Cresol sulfate, and 3-carboxy-4-methyl-5-pentyl-2-furanpropanoic acid were found associated with the progress of HSP to HSPN. Moreover, resulting biomarkers, when combined with D-dimer, allowed improving the HSPN prediction with high sensitivity (94.7%) and specificity (80.8%). Together these findings highlighted the strength of the combination of metabonomics and clinical analysis in the research of HSP.
Value of the Oxford classification of IgA nephropathy in children with Henoch–Schönlein purpura nephritis

Ke Xu,Lili Zhang,Jie Ding,Suxia Wang,Baige Su,Huijie Xiao,Fang Wang,Xuhui Zhong,Yanming Li

DOI: https://doi.org/10.1007/s40620-017-0457-z

IF: 4.4061

2017-01-01

Journal of Nephrology

Abstract:Background The widely used International Study of Kidney Disease in Children (ISKDC) classification for Henoch-Schönlein purpura nephritis (HSPN) does not completely correlate with the clinical presentation and long-term prognosis of this disease. Primary IgA nephropathy (IgAN) and HSPN share common features; thus, the Oxford classification of IgAN might be useful in predicting the long-term outcomes of HSPN. However, its value has not been confirmed in children with HSPN. Methods We selected children with HSPN diagnosed between 2003 and 2015, and reclassified their renal biopsies according to the Oxford classification scoring system. The primary outcome was impaired renal function, and remission of proteinuria and clinical remission were secondary outcomes. Results We included 104 patients (58 males, 46 females) with a median age of 10 (4–17) years. Mesangial hypercellularity (M1) was strongly associated with proteinuria, and tubular atrophy/interstitial fibrosis (T1&2) and C2 (with crescents in > 25% of glomeruli) were associated with reduced estimated glomerular filtration rate (eGFR) at the time of biopsy. Patients with M1, endocapillary proliferation (E1), segmental glomerulosclerosis (S1), and crescents (C1&2) were more likely to have been treated with high-dose methylprednisolone. At univariate time-dependent analyses, S1 was strongly associated with the primary outcome (p = 0.025), whereas T1&2 was significantly negatively associated with proteinuria remission (p = 0.035) and clinical remission (p = 0.038). Conclusions Our findings suggest that the Oxford classification is valid for children with HSPN. S and T lesions, which are ignored in the ISKDC classification, can be used to assess renal outcomes of HSPN, and such assessments are not affected by currently available treatments. The value of M, E and C lesions in predicting response to therapy and renal outcome warrants further study.
Diagnosing Chronic Fatigue Syndrome in South Asians: Lessons from a Secondary Analysis of a UK Qualitative Study

RErandie Ediriweera De Silva,K. Bayliss,L. Riste,CarolynA Chew-Graham

DOI: https://doi.org/10.4103/2249-4863.120765

2013-07-01

Journal of Family Medicine and Primary Care

Abstract:Background: Chronic fatigue syndrome/myalgic encephalitis (CFS/ME) is rarely diagnosed in South Asia (SA), although the symptoms of this condition are seen in the population. Lessons from UK based South Asian, Black and Minority Ethnic (BME) communities may be of value in identifying barriers to diagnosis of CFS/ME in SA. Objectives: To explore why CFS/ME may not be commonly diagnosed in SA. Settings and Design: A secondary analysis of qualitative data on the diagnosis and management of CFS/ME in BME people of predominantly South Asian origin in the UK using 27 semi-structured qualitative interviews with people with CFE/ME, carers, general practitioners (GPs), and community leaders. Results: CFS/ME is seen among the BME communities in the UK. People from BME communities in the UK can present to healthcare practitioners with vague physical complaints and they can hold a biomedical model of illness. Patients found it useful to have a label of CFS/ME although some GPs felt it to be a negative label. Access to healthcare can be limited by GPs reluctance to diagnose CFS/ME, their lack of knowledge and patients negative experiences. Cultural aspects among BME patients in the UK also act as a barrier to the diagnosis of CFS/ME. Conclusion: Cultural values and practices influence the diagnosis of CFS/ME in BME communities. The variations in the perceptions around CFS/ME among patients, carers, and health professionals may pose challenges in diagnosing CFS/ME in SA as well. Raising awareness of CFS/ME would improve the diagnosis and management of patients with CFS/ME in SA.
Preliminary analysis of urinary proteome of children minimal change nephrotic syndrome by two-dimensional gel electrophoresis and PDQuest software based image analysis

Yan-Jun HUANG,Song-Ming HUANG,Ai-Hua ZHANG,Li FEI,Song-Zhou XU,Rong-Hua CHEN

2006-01-01

Abstract:AIM: To analyze the urinary proteome of children minimal change nephrotic syndrome by the two-dimensional gel electrophoresis (2DGE) and PDQUEST software based image analysis. METHODS: The urinary protein of children nephrotic syndrome was isolated by cold acetone precipitation, treated to remove high abundance proteins by Aurum Serum Protein Kit and desalted by ReadyPrep~ TM 2-D Cleanup Kit. The rehydrated immobilized pH gradient (IPG) strips containing protein samples were isoelectric focusing (IEF). After IEF, the equilibrated strips were transferred to the vertical SDS-polyacrylamide gel. The silver stained gels were scanned by UMAX PowerLook 1120 densitometer to acquire the digitalized images. Using new generation two- dimensional image analysis software, PDQuest 7.3, the 2DGE of proteins extracted from urine was processed. The analysis procedure, including image acquirement, automated spot detection and quantification and analysis result report, was carried out. The method and the volume of loading sample, the choice of IPG gels, the concentration of SDS gels and the protocol for staining procedure were improved. RESULTS: Using the proper method stated above, satisfactory 2DGE maps of urinary protein were obtained and the preliminary analysis results were reported. The reasonable sample load and Volt-hours of urinary protein were about 100 μg and 60 000 Volt-hours for the 17 cm pH3-10 IPG strips. A total of 400 protein spots were visualized with PDQuest 7.3 software. CONCLUSION: Urinary proteomics can be applied in the study of urine protein of children minimal change nephrotic syndrome. We have used proteomic method to construct protein maps of urinary protein of children minimal change nephritic syndrome. At the level of proteome, we may use urinary proteomic techniques to find functional proteins and specific proteins (protein biomarker) of renal disease in the future and the technique will be further used in renal research to characterize network mechanisms of physiological processes and the disease.
Specific immune biomarker monitoring in two children with severe IgA nephropathy and successful therapy with immunoadsorption in a rapidly progressive case

Alexandra Cambier,Claire Dossier,Julien Hogan,Véronique Baudouin,Anne Maisin,Anne Couderc,Theresa Kwon,Patrick J Gleeson,Renato C Monteiro

DOI: https://doi.org/10.1007/s00467-021-05381-5

Abstract:Background: Childhood IgA nephropathy (cIgAN) is one of the most common primary glomerulonephritides with the potential to evolve to kidney failure. IgAN is an autoimmune disease involving 3 key factors: galactose-deficient IgA1 (Gd-IgA1), anti-IgA1 autoantibodies, and soluble (s)CD89 IgA Fc receptor. These molecules and immune complexes have been described recently as potential biomarkers of disease progression in childhood IgAN but their evolution in time under immunosuppressive treatment remains unknown. Methods: We performed a prospective study of two proliferative cIgAN patients by sequentially biomonitoring immune IgA complexes (sCD89-IgA, IgG-IgA), sCD89, and Gd-IgA1 and correlating them with clinical and histological outcome after treatment. Results: After patient 1's treatment, a decrease in sCD89-IgA, IgG-IgA, and free sCD89 was linked to a decrease in proteinuria whereas eGFR (estimated glomerular filtration rate) and Gd-IgA1 levels remained stable. Patient 1 received tacrolimus and monthly intramuscular steroid injections of Kenacort for 10 months. At the end, a relapse induced an increase in proteinuria consistent with an increase of the 3 biomarkers. Patient 2 displayed rapidly progressive IgAN with crescents in more than 90% of glomeruli and received intense immunosuppression treatment associated with the immunoadsorption (IA) approach. During IA, proteinuria decreased rapidly, as well as levels of CD89-IgA, IgG-IgA, sCD89, and Gd-IgA1 biomarkers. After discontinuation of IA, proteinuria increased as well as IgG-IgA complexes whereas sCD89-IgA and sCD89 remained low. Further re-intensification of IA and addition of cyclophosphamide improved proteinuria again with reduced IgG-IgA. A second biopsy was performed showing a reduction of extracapillary proliferation to 6% of glomeruli and only 9% glomerulsoclerosis. Conclusions: In conclusion, sequential biomonitoring of Gd-IgA1, IgA-immune complexes, and sCD89 in cIgAN was found to be valuable, by correlating with clinical features and glomerular proliferative lesions in cIgAN. These biomarkers could represent useful tools to evaluate kidney injury without repeat kidney biopsies.
Urinary complement profile in IgA nephropathy and its correlation with the clinical and pathological characteristics

Dongqing Wang,Changwei Wu,Sipei Chen,Yi Li,Li Wang,Yong Zhang,Guisen Li

DOI: https://doi.org/10.3389/fimmu.2023.1117995

2023-03-20

Abstract:Background and objectives: The activated complement profile in IgA nephropathy (IgAN) is still unclear. Our study investigated the profile of urinary complements in IgAN patients and its correlations with clinical and pathological characteristics. Methods: Urinary protein abundance was detected by liquid chromatography-tandem mass spectrometry (LC-MS/MS) in 50 IgAN, 50 membranous nephropathy (MN), and 68 healthy controls (HC). Then, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed to identify differentially expressed proteins in IgAN patients. The differentially expressed complement proteins were screened in IgAN patients, and their correlations with laboratory or pathological parameters were analyzed. Thereafter, 7 complement components were validated by enzyme-linked immunosorbent assay (ELISA) in the urine samples of 45 IgAN patients. Results: There were 786 differentially expressed proteins between IgAN and HC. KEGG analysis showed that differentially expressed urinary proteins in IgAN were enriched with complement. Of these, 67% of urinary complement protein abundance was associated with the estimated glomerular filtration rate. The urinary complement-related protein collectin12 (colec12), complement H factor (CFH), complement H factor-related protein 2 (CFHR2), and complement B factor (CFB) were positively correlated with serum creatinine; colec12, CFHR2, CFB, and C8g were positively correlated with glomerulosclerosis; CFH, CFHR2, C8g, and C9 were positively correlated with tubular atrophy/interstitial fibrosis. Conclusion: Abnormally increased components of complement pathways significantly correlate with reduced renal function, proteinuria, and renal histological damage in IgAN. It could provide a potential biomarker panel for monitoring IgAN and provide clues for therapeutic choice targeting complement system of IgAN patients.
Electrophoretic methods for analysis of urinary polypeptides in IgA-associated renal diseases

Bruce A Julian,Stefan Wittke,Jan Novak,David M Good,Joshua J Coon,Markus Kellmann,Petra Zürbig,Eric Schiffer,Marion Haubitz,Zina Moldoveanu,Shannon M Calcatera,Robert J Wyatt,Josef Sýkora,Eva Sládková,Ondrej Hes,Harald Mischak,Brendan M McGuire

DOI: https://doi.org/10.1002/elps.200700237

Electrophoresis

Abstract:We evaluated the utility of SDS-PAGE/Western blot and CE coupled with MS (CE-MS) for detection of urinary polypeptide biomarkers of renal disease in patients with IgA-associated glomerulonephritides. In a reference cohort of 402 patients with various renal disorders and 207 healthy controls, we defined CE-MS patterns of renal damage and IgA nephropathy (IgAN). In a blinded analysis of a separate cohort of patients with IgAN (n = 10), Henoch-Schoenlein purpura (HSP) with nephritis (n = 10), and IgA-associated glomerulonephritis due to hepatitis C virus (HCV)-induced cirrhosis (n = 9), and healthy controls (n = 12), we compared SDS-PAGE/Western blot and CE-MS against clinical urinalysis for detection of urinary proteins/polypeptides. Urinalysis indicated proteinuria for 50, 90, and 33% of patients, respectively, and for none of the healthy controls. SDS-PAGE/Western blot showed urinary polypeptides abnormality for 90, 80, and 67% of patients, respectively, and for none of the healthy controls. CE-MS indicated a Renal Damage Pattern in 80, 80, and 100 of patients, respectively, and in 17% of healthy controls, with the more specific IgAN Pattern in 90, 90, and 1%, respectively, and in none of the healthy controls. Based on differences in CE-MS patterns, the disease mechanisms may differ among various IgA-associated glomerulonephritides. These exploratory findings should be evaluated in a prospective study with contemporaneous renal biopsy and urinary testing. If validated, it may be feasible to adapt the CE-MS methodology to develop novel tests to detect renal injury at earlier stages, assess clinical manifestations, and monitor responses to therapy in patients with IgA-associated renal diseases.
Increased Urinary Exosomal Micrornas in Children with Idiopathic Nephrotic Syndrome

Tingting Chen,Cheng Wang,Hanqing Yu,Meng Ding,Cuiping Zhang,Xiaolan Lu,Chen-Yu Zhang,Chunni Zhang

DOI: https://doi.org/10.1016/j.ebiom.2018.11.018

IF: 11.205

2019-01-01

EBioMedicine

Abstract:Background: Urinary exosomal miRNAs are gaining increasing attention for their potential as ideal non-invasive biomarkers for kidney diseases; however, little is known about their diagnostic ability for paediatric nephrotic syndrome (NS). This study explored the clinical value of urinary exosomal miRNAs for paediatric idiopathic NS. Methods: Urine samples were collected from 129 NS children and 126 age-/sex-matched healthy controls. The miRNA profile of urinary exosomes was analysed by high-throughput Illumina sequencing via synthesis (SBS) technology followed by verification with a quantitative reverse-transcription polymerase chain reaction (RTqPCR) assay arranged in two independent cohorts. Additionally, paired urine samples from 65 of these patients were collected before and after treatment. Findings: The Illumina SBS identified 30 markedly increased urinary exosomal miRNAs in NS children compared with controls (>= 5-fold, P < .05). Fifteen miRNAs were selected for further investigation, of which 5 (miR-194-5p, miR-146b-5p, miR-378a-3p, miR-23b-3p and miR-30a-5p) were verified by RT-qPCR to be significantly and steadily increased in NS (>3-fold, P < .01) and markedly reduced during the clinical remission period (P < .001). Moreover, the concentrations of miR-194-5p and miR-23b-3p were significantly positively correlated with the urine protein content and were markedly higher in the high urine protein group than in the low urine protein group (P < .001 and P < .01, respectively). Interpretations: We identified 5 altered urinary exosomal miRNAs in NS children with disease progression and treatment. These urinary exosomal miRNAs could be promising and non-invasive potential biomarker candidates for diagnosing, monitoring and stratifying paediatric NS. Fund: National Natural Science Foundation of China; Fund of State Key Laboratory of Analytical Chemistry for Life Science; National Basic Research Programme of China; Foundation of Jiangsu Provincial Medical Youth Talent. (c) 2018 The Authors. Published by Elsevier B.V.

C-reactive protein, heart disease risk, and the popular media.

Integrated Proteomics and Metabolomics to Study IgA Nephropathy on Early Stage and Identification of Biomarkers

Urinary Proteome Analysis by Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight Mass Spectrometry with Magnetic Beads for Identifying the Pathologic Presentation of Clinical Early Iga Nephropathy

Itraq-Based Comparative Proteomics Analysis Reveals Specific Urinary Biomarkers for Various Kidney Diseases.

Proteome analysis reveals novel serum biomarkers for Henoch-Schönlein purpura in Chinese children

Identification of the Pathologic Presentation of Clinical Early IgA Nephropathy by MALDI-TOF-MS with Magnetic Beads

Mouse peripherin isoforms

Updated Oxford classification and the international study of kidney disease in children classification: application in predicting outcome of Henoch-Schönlein purpura nephritis

Preliminary Analysis on Urinary Proteomics of Children with Minimal Change Nephrotic Syndrome

Urinary complement proteins in IgA nephropathy progression from a relative quantitative proteomic analysis

Proteomic Profile-Based Screening of Potential Protein Biomarkers in the Urine of Patients with Nephrotic Syndrome

Urinary biomarkers of IgA nephropathy and other IgA-associated renal diseases

Angiopoietin-like Protein 3: a Novel Potential Biomarker for Nephrotic Syndrome in Children

Biomarkers identification by a combined clinical and metabonomics analysis in Henoch-Schonlein purpura nephritis children

Value of the Oxford classification of IgA nephropathy in children with Henoch–Schönlein purpura nephritis

Diagnosing Chronic Fatigue Syndrome in South Asians: Lessons from a Secondary Analysis of a UK Qualitative Study

Preliminary analysis of urinary proteome of children minimal change nephrotic syndrome by two-dimensional gel electrophoresis and PDQuest software based image analysis

Specific immune biomarker monitoring in two children with severe IgA nephropathy and successful therapy with immunoadsorption in a rapidly progressive case

Urinary complement profile in IgA nephropathy and its correlation with the clinical and pathological characteristics

Electrophoretic methods for analysis of urinary polypeptides in IgA-associated renal diseases

Increased Urinary Exosomal Micrornas in Children with Idiopathic Nephrotic Syndrome